Podcasts about chief science

In this episode, we take a deep dive into the state of the treatment pipeline for bleeding disorders. From the way clinical trials are structured to what's actually available for different conditions, we examine both the promise and the reality of innovation in this space. Recorded live at the NBDF Bleeding Disorders Conference, we join Mike Recht, MD, PhD, Chief Science and Medical Officer of NBDF, for a “research posters walk & talk” to explore what's happening right now — and why so many promising treatments never make it to market. Guests: Mike Recht, MD, PhD Maria Santaella, PhD(c), MSN, RN-BC, CPHON Samantha Carlson, LMSW   Senior Advisor: Donna DiMichele, MD   Hosted by: Patrick James Lynch   Written by: Kay Vermeil   Featured Advertiser: Sanofi   Subscribe to the Global Hemophilia Report   Show Notes:   Join Kevin as he shares about his journey with hemophilia and the hurdles he faced in communicating with friends, family, and healthcare providers about his condition. He highlights how hemophilia affects far more than just physical health — and why honest, open conversations that focus on the full patient experience, not just symptoms, are so essential.   Click here to watch his story: https://www.youtube.com/watch?v=3v1cCTbhClA&list=PLmqBxf22n4lNK82h3QZ-9YlpIjYdzDOer&index=5   Sanofi's Global Hemophilia Survey uncovers significant care gaps and emotional challenges faced by patients and caregivers. Learn how improving health literacy and fostering better patient-provider communication are essential to addressing these inequities. Explore the findings and see how Sanofi is driving health equity for the hemophilia community. Explore the survey findings here: Global Hemophilia Survey Page. Connect with the Global Hemophilia Report Global Hemophilia Report on LinkedIn Global Hemophilia Report on X/Twitter Global Hemophilia Report on Facebook   Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook  BloodStream on X/Twitter   

DairyNZ's Chief Science and Innovation Officer says its plantain programme continues to deliver promising results, with new data confirming that modest levels of plantain in pastures reduce nitrogen leaching, offering farmers a practical, science-backed tool to meet environmental goals.See omnystudio.com/listener for privacy information.

Today's episode features guest host Michael Upshall (guest editor, Charleston Briefings) who talks with Richard Sever, Assistant Director, Cold Spring Harbor Laboratory Press. Richard earned his PhD in molecular biology and has been with Cold Spring Harbor for over 17 years. He recently became Chief Science and Strategy Officer at Open Archive, which oversees bioRxiv and medRxiv. Richard says he has always been fascinated with figuring out how things work, and that led him to a career in science. He realized that he didn't want a career in academic research but enjoyed science communication instead. Richard moved into scientific publishing, enjoying the range of topics and collaboration with authors, and eventually chose Cold Spring to work with because of the high caliber research and mission driven innovation there.  Richard and his colleague John Inglis founded bioRxiv, a biology preprint server, with hopes to improve how science is evaluated and shared.   The video of this podcast can be found here: https://youtu.be/9dOa9gJy1Y0 Social Media: LinkedIn: https://www.linkedin.com/in/mupshall/ https://www.linkedin.com/in/richardsever/ Twitter: Keywords: #ColdSpringHarbor #BioRxiv #MedRxiv #STEMCareers #ResearchInnovation #OpenScience #ScientificPublishing #SciComm #ScienceCommunication #preprints #career #collaboration #scholcomm #ScholarlyCommunication #libraries #librarianship #LibraryNeeds #LibraryLove #ScholarlyPublishing #AcademicPublishing #publishing #LibrariesAndPublishers #podcasts

On this episode of The Kara Goldin Show, we're joined by Dr. Christina Rahm, scientist, entrepreneur, humanitarian, and Chief Science Formulator at The ROOT Brands. She's also the CEO of DRC Ventures, a global platform focused on science, sustainability, and impact-driven innovation. With degrees in nanotechnology, pharmaceutical management, and nutrition—plus a personal healing journey that includes overcoming Lyme disease and multiple cancers—Dr. Rahm brings a unique blend of science and soul to everything she does.During our conversation, Christina shares how The ROOT Brands was born from a mission to go deeper than surface-level wellness—to address the actual root causes of disease and dysfunction. We explore how her formulations support detoxification and cellular restoration, why quick fixes don't lead to real healing, and what most people get wrong about health in the first place. She also gives us a look into her work with DRC Ventures and the Rahm Foundation, and how she's driving global change in 89 countries while staying laser-focused on the science.Whether you're a wellness entrepreneur, a seeker of true health, or someone who's been told “you've tried everything,” this episode offers real tools, bold thinking, and the truth about what it takes to truly heal. Now on The Kara Goldin Show. Are you interested in sponsoring and advertising on The Kara Goldin Show, which is now in the Top 1% of Entrepreneur podcasts in the world? Let me know by contacting me at karagoldin@gmail.com. You can also find me @‌KaraGoldin on all networks. To learn more about Dr. Christina Rahm, The ROOT Brands, and DRC Ventures:https://www.instagram.com/drchristinarahm/https://therootbrands.comhttps://www.drc-ventures.com Sponsored By:Shopify - Sign up for your one-dollar-per-month trial period at Shopify.com/kara Check out our website to view this episode's show notes: https://karagoldin.com/podcast/682

Dr. Aristo Vojdani discusses Precision Environmental Medicine with moderator Dr. Ben Weitz at the Functional Medicine Discussion Group meeting on February 27, 2025.   [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]    Podcast Highlights     Dr. Aristo Vojdani is Father of Functional Immunology and he has dedicated his life's research to helping us figure out what are the triggers for autoimmune diseases and many of the tests he has developed for Cyrex Labs are focused on this.  Dr. Vojdani has a PhD in microbiology and immunology and he has authored over 200 scientific papers published in peer reviewed journals. Dr. Vojdani is the co-owner of Immunosciences Lab in Los Angeles, which offers testing for various types of infections, including Lyme Disease. He is the Chief Science advisor for Cyrex Labs, whom he has developed all of the testing for, including the Lymphocyte Map test, Array 2 for Leaky Gut, and Array 5, The Multiple Autoimmune Reactivity Panel.  Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

Are you wondering how to pivot from academia to the neurotech industry without starting from scratch? Many assume that moving from a PhD to industry means leaving much of their academic experience behind, but that's not necessarily the case. Welcome to this episode of Neurocareers: Doing the Impossible!, where we uncover how advanced academic skills can be a powerful asset in the neurotech sector. Today, we're honored to have Dr. Mustafa S. Hamada, Chief Science and Product Officer at Mendi Innovations in Sweden, share invaluable insights on leveraging PhD skills to break into and excel in neurotechnology. Dr. Hamada, a trailblazer in integrating neuroscience with product innovation, will guide us through how we can translate academic expertise into industry success. He'll reveal what industry employers are looking for during interviews, discuss the benefits of being a generalist versus a specialist, and provide tips on navigating the job market with your unique skills. Moreover, we'll dive into the strategic choices that can shape your career path: selecting the right company size, the importance of mentorship, and working in start-up environments. Dr. Hamada will also touch on the impact of AI in neurotech, compare the job markets in Europe and the US, and forecast the future of the industry. If you're eager to learn how your PhD can open doors in the neurotech field, and you want to know what it takes to stand out to employers and thrive in this dynamic industry, then tune into Dr. Hamada's expert advice and personal journey. Transform your academic achievements into your industry advantage with insights from a leading expert in neurotech. Let's discover how to leverage your PhD for success in the fast-evolving world of neurotechnology together! About the Podcast Guest: Dr. Mustafa S. Hamada is the Chief Science and Product Officer at Mendi Innovations, a neurotechnology startup in Sweden. Dr. Hamada drives the integration of advanced neuroscience into innovative product development, focusing on neurotechnology, behavioral design, and AI to enhance brain health solutions. He was also a recipient of the Grand Prize for Engineering in Innovation 2024. Work email: mustafa@mendi.io LinkedIn: www.linkedin.com/in/mustafashamada   About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Send us a textDr. Nina Siragusa, Ph.D., MBA, is the Strategy, Business, and Data & Digital Lead within the global R&D organization of Merck Healthcare KGaA, Darmstadt, Germany. In this role, she leads strategic projects, manages business operations, and drives digital transformation.Previously, she served as Chief of Staff to Dr. Laura Matz, Chief Science and Technology Officer at Merck KGaA, Darmstadt, Germany. As part of the Science and Technology Office Leadership Team, she was responsible for fostering cross-sectoral collaboration, innovation, and digitalization across Merck's three business sectors. She also spearheaded the company's efforts in Bioconvergence, a multidisciplinary approach that synergizes biology, engineering, data, and digitalization. This initiative promises groundbreaking advancements in healthcare and the life sciences, heralding a new era of scientific collaboration for a healthier, more sustainable future.Prior to that, Dr. Siragusa contributed to corporate innovation in several leadership roles:• As Biotechnology Lead of a synthetic biology innovation project,• As Senior Manager, responsible for creating strategic alignment and building high-performing teams, and• As Associate Director, focusing on sourcing innovative ideas to generate new business opportunities.Dr. Siragusa earned her Ph.D. in Biology from the University of Tuebingen, Germany, and conducted research in Europe and the USA, including at Yale University, before joining Merck KGaA, Darmstadt, Germany in 2016.In 2024, she completed an MBA in Digital Transformation Management with a focus on Digital Leadership at Goethe Business School, Frankfurt, Germany.Dr. Siragusa is also the lead author of the recently published book, Bioconvergence Revolution: Challenges and Opportunities in Research Productivity. You can find it here: https://link.springer.com/book/10.1007/978-3-031-61593-1Home Page Merck KGaA Darmstadt, Germany - https://www.emdgroup.com/en#NinaSiragusa #EMDGroup #MerckKGaADarmstadtGermany #Bioconvergence #Ethics #Collaboration #Fungi #NaturalProducts #Biomimicry #AI #DrugDiscovery #Bioremediation #TranslationalMedicine #SmartManufacturing #DigitalTwins #Supermind #MIT #ResearchFunding #Israel #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcastSupport the show

Dr. Bruce Strober, MD, PhD, dermatologist and JPPA Editor-in-Chief, and Guy Eakin, PhD, Chief Science and Medical Officer at the NPF discuss the Journal of Psoriasis and Psoriatic Arthritis path to indexing and what it means for the research community moving forward.    This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

The body is not a machine, nor a temple. It is an infinitely complex and unique system, and according to Dr. Ralph Esposito, Chief Science & Nutrition Officer at AG1, it's one we know less about than we think. Dr. Ralph is a naturopathic physician and gut health expert, and he joins host Casey Bannon to discuss the science behind whole-body wellness. Rather than broad-spectrum advice, Dr. Ralph offers approachable insights into how your body works. This information-rich chat touches on the significance of sleep, the dangers in some diet trends, the proper way to fuel your brain and body and much more. Plus, you'll learn the science-backed reason that your favorite Tour pros are munching on the same food at the same point in every round. Get 10 free AG1travel packs when you subscribe: https://drinkag1.com/event/bts24 Gift the #1 Ball in Golf: https://www.titleist.com/ Subscribe to The Golfer's Journal: https://www.golfersjournal.com/ All Mind Game episodes: https://www.golfersjournal.com/category/mind-game-podcast/

The Trump-Vance transition team and the Biden administration signed a memorandum of understanding last week formally kicking off the process to hand over executive power — though the Trump team has decided not to accept some of the government's available resources, including tech and information security provided by the General Services Administration. The transition team will reportedly run as a “self-sufficient organization” with existing security and information protections already built-in, utilizing private funding, according to the press release from the Trump transition team. That includes not using technology or buildings provided by the General Services Administration as part of the transition resources the agency is authorized and appropriated to provide. The Trump team said it “already has existing security and information protections built in, which means we will not require additional government and bureaucratic oversight.” The Department of Justice's Office of the Inspector General called out the agency's lack of an updated public strategy for artificial intelligence and underscored the need to be proactive in a report on its management and performance challenges last week. The comments came as part of the OIG's determination that maintaining cybersecurity and keeping up with emerging technologies, such as AI, were among the top challenges for the DOJ. For AI specifically, the report underscored how long ago the department's public AI strategy was released. The OIG's office said in the report: “While the Department has made efforts to adapt to the change in the technological landscape, such as hiring the Department's first Chief Science and Technology Advisor and Chief AI Officer, the most recent publicly issued strategy on AI from the Department—which outlines an AI adoption and coordination strategy with DOJ component responsibilities—is from 2020.” The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

Dr. David Dodick is a notable neurologist and the Chief Science and Medical Officer of Atria. He joins Martha to discuss the latest research about lifestyle interventions that help reduce cognitive decline, actionable ways to optimize your brain health, and when to be worried. He also shares tips for stroke prevention and explains why sleep is really the most important thing you can do for the body.See omnystudio.com/listener for privacy information.

Today I'm joined by Jayshree Seth, Corporate Scientist and Chief Science Advocate at 3M, who discusses our relationship with science and engineering and the important role it plays in innovation, problem solving, and professional and personal growth.   Show notes and further links:   Jayshree's 3rd book in the ‘Heart of Science' series, ‘The Heart of Science: Engineering Blueprint': https://a.co/d/7DUD3lv Fast Company article with Prof Amy Edmondson: https://www.fastcompany.com/91012097/4-big-morale-busting-communication-mistakes-leaders-should-stop-making Fast Company article with Prof Rita McGrath: https://www.fastcompany.com/90954158/a-guide-for-managing-innovation-4-big-mistakes-technologists-wish-their-business-leaders-would-quit-making Drucker Forum blog article on sustainable innovation: https://www.druckerforum.org/blog/the-3-cs-of-sustainable-innovationby-jayshree-seth/     Sponsored by https://www.b2bframeworks.com Brought to you in partnership with https://awardsinternational.com 

A signficant situation vacant is causing concern in the science world and beyond. The government won't say whether it's keeping role of Prime Minister's Chief science advisor; a job that has been empty since July. That's despite the coalition agreement saying "decisions will be based on data and evidence."Among other things the chief science advisor provides advice on specific topics to the PM and Ministers and information in a crisis like, the covid pandemic. However, past advice from Prime Ministerial science advisors on dealing with gangs, a rising prison population , and boot camps has run contrary to a number of policies the current government's adopted. The budget for the office has also been cut by half a million dollars. Simon Kingham was Chief Science advisor to the NZTA, up until May this year and spoke to Lisa Owen.

In this episode, Dom Hawes interviews cognitive neuroscientist Carmen Simon, uncovering how brain science can help marketers ensure their content is remembered. Carmen highlights the importance of focusing on distinctiveness and emotion to make sure your audience recalls the most crucial parts of your message. By understanding how the brain processes and retains information, marketers can begin crafting content that truly sticks, helping brands stand out in today's crowded digital space.Key points:Why distinctiveness helps capture and keep audience attention.How emotions play a key role in enhancing memory retention.The practical application of neuroscience tools like EEGs and eye-tracking in content strategy.Defining your "10% message" to ensure you focus on what matters most to your audience.Catch the full episode for more on how neuroscience can transform your marketing approach.Competition time!

In this episode, Dom Hawes interviews cognitive neuroscientist Carmen Simon, uncovering how brain science can help marketers ensure their content is remembered. Carmen highlights the importance of focusing on distinctiveness and emotion to make sure your audience recalls the most crucial parts of your message. By understanding how the brain processes and retains information, marketers can begin crafting content that truly sticks, helping brands stand out in today's crowded digital space.Key points:Why distinctiveness helps capture and keep audience attention.How emotions play a key role in enhancing memory retention.The practical application of neuroscience tools like EEGs and eye-tracking in content strategy.Defining your "10% message" to ensure you focus on what matters most to your audience.Catch the full episode for more on how neuroscience can transform your marketing approach.Competition time!

Dr. Hoffman continues his conversation with molecular biologist Pita Navarro, co-founder and Chief Science officer at Evvy, pioneering the research to improve diagnostics and treatments for underserved conditions in the female body.

Dr. Joe Parker is our guest. Listen to what led to his prison sentence. Dr. Parker's Bio Dr. Joseph Parker's career spans the fields of science, military service, and medical practice. He has used his rare blend of scientific expertise, military leadership, and medical acumen to contribute significantly to the advancement of science and the betterment of human health and safety. He writes as an advocate for physicians and patients and for the humane treatment of those suffering from addiction and the incarcerated. His journey towards this impactful role began with four years of dedicated service in the US Marine Corps, where he earned accolades such as the Meritorious Unit Citation and Good Conduct Medal. His exceptional service led to acceptance into the US Air Force Officer Training School and a subsequent role as a Minuteman II ICBM Commander within US Space Command, earning further recognition, including the Presidential Unit Citation, National Defense Service Medal, and the Air Force Achievement Medal. Transitioning into the medical field, Dr. Parker pursued studies at Mayo Medical School and joined the US Medical Corps, ultimately achieving the rank of Captain. Having personally suffered wrongful convictions gives him a unique perspective on the American justice and prison system, and he has dedicated himself to advocacy for the wrongfully prosecuted. He is currently serving as the Chief Science and Operations Officer at Advanced Research Concepts LLC, a pioneering company dedicated to biomedical research to alleviate pain and addiction, and to the development of innovative solutions for the complex challenges of space travel, including spacecraft propulsion systems, energy storage, radiation shielding, artificial gravity, and space-related medical issues.  He is also active in biomedical research, space science, and the study and treatment of addiction. The information in this podcast is not to be considered medical or legal advice

Omico is leading Australia's largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international trials to Australia.Professor David Thomas, renowned for his groundbreaking work in precision oncology, is the founder and Chief Science and Strategy Officer of Omico - the Australian Genomic Cancer Medicine Centre. In this episode, host Caroline Duell speaks with Professor Thomas to find out more about his mission to open up new treatment options for all cancer patients using genomics, the impact of pan tumour therapies on our healthcare system, and why we need to change the way we look at cancer care and cure right now before more people die unnecessarily.

Today we are making nature great again with Rob Waterworth, Co-Founder & Chief Science and Innovation Officer at FLINTpro. The company enables managing and reporting emissions and nature risks across a portfolio. Clients may understand the Scope 1 and 3 emissions liability, deforestation risk, and biodiversity impact of their portfolio and future investment opportunities. The company also assists to navigate evolving disclosure requirements and generate audit-ready reports. Additionally, they help identify emissions reduction and value creation opportunities to reach a client's climate commitments. THE GEOSPATIAL INDEX The Geospatial Index is a comprehensive listing of all publicly traded geospatial businesses worldwide. Why? The industry is growing at ~10% annually. This varies significantly, however, by sub index. For only $58,000 to start, this growth rate is $5,000,000 over a working life. This channel, Bluesky account, newsletter, watchlist and podcast express the view that you are serious about geospatial if you take the view of an investor, venture capitalist or entrepreneur. You are expected to do your own research. This is not a replacement for that. This is not investment advice. Consider it entertainment. NOT THE OPINION OF MY EMPLOYER NOT YOUR FIDUCIARY NOT INVESTMENT ADVICE Bluesky: https://bsky.app/profile/geospatialindex.bsky.social LinkedIn: https://uk.linkedin.com/in/geospatialindex Watchlist: ⁠https://www.tradingview.com/watchlists/123254792/ Newsletter: https://www.geospatial.money/ Podcast: https://open.spotify.com/show/5gpQUsaWxEBpYCnypEdHFC

Join host Lara Birkes as she interviews Robert Waterworth, Co-founder and Chief Science, Policy, and Innovation Officer at FLINTpro. Discover how FLINTpro is revolutionizing the way businesses understand and mitigate their environmental impact through cutting-edge data integration and analytics. Key topics covered: FLINTpro's journey from carbon accounting to comprehensive nature impact assessment; The importance of integrated data approaches in environmental analysis; FLINTpro's key offerings: advanced analytics, insights products, and regulatory risk mapping; How businesses can use FLINTpro to guide environmental strategy and compliance; The future of nature-related data in corporate decision-making. Whether you're a sustainability professional, business leader, or simply interested in the intersection of technology and environmental protection, this episode offers valuable insights into the tools shaping our understanding of business impacts on nature. learn more: https://www.flintpro.com/ #NatureIS #FLINTpro #Sustainability #EnvironmentalImpact #ClimateChange #Biodiversity # About Better Worlds We believe that the digital transformation and related technologies are revolutionizing the very nature of the way we live and who we are. Done right, these innovations can help lead us to a better world. We're here to bring together the people and the tools to help you build it. One key focus of our mission is to explore how the innovations of Web3, Ai, and Quantum Computing can help to sustain the natural world and build greater efficiencies to grow our shared prosperity. We believe in creating a collaborative, inclusive, and sustainable community to explore innovative solutions. Solutions that will contribute to achieving bioregional and global prosperity by integrating our three interconnected worlds: the natural world, the human-made physical world, and emerging technologies. @BetterWorlds seeks to explore alternative viewpoints through media, international conferences, symposia, essays and hack-a-thons that encourage and support the development of innovative solutions. Visit our website- https://www.betterworlds.com/ Follow for more updates https://www.linkedin.com/company/betterworlds/ https://twitter.com/onemetaworld

Op Instagram wordt massaal een afbeelding gedeeld met de tekst "All eyes on Rafah". De foto over de stad in de Gazastrook is inmiddels door 42 miljoen mensen geplaatst. Nooit eerder werd een AI-gegenereerde afbeelding met een activistisch doel zo veel gedeeld. Een unieke situatie, zegt Michiel Jurrjens in de Tech Update.Omdat de "All eyes on Rafah"-leus in de afbeelding zelf verwerkt is, ontglipt deze de moderatie van Instagram-moederbedrijf Meta. Berichten over de oorlog in de Gazastrook zijn niet verboden op de platforms van Meta, maar worden slechts beperkt getoond. Verder in de Tech Update: De Algemene Inlichtingen- en Veiligheidsdienst (AIVD) kondigt vandaag een nieuw op te richten Chief Science & Technology Office aan. "De snelheid waarmee technologische ontwikkelingen zich voltrekken dwingt ons om proactief zijn. Daar is een goede visie en een gecoördineerde aanpak voor nodig", zegt directeur-generaal Erik Akerboom van de AIVD.  Barista's van Starbucks klagen over onderbezetting en wijten die aan een nieuw algoritme, meldt Bloomberg. Dat systeem gaat uit van orderprognoses en productbeschikbaarheid, maar houdt volgens de werknemers onvoldoende rekening met het toenemende aantal speciale wensen van klanten, zoals extra espresso of koud schuim. Het algoritme onderschat daardoor hoe veel personeel er nodig is. Klanten moeten daardoor steeds langer wachten, zeggen de werknemers. See omnystudio.com/listener for privacy information.

This week, our Chief Science Officers from Dow High talk about their action plans and the overall responsibilities of a CSO. Sahiba Kaur (Junior), and Preston Komara (Freshman) tell us their story and how they embraced their roles. Record Date 2/16/2024 Release Date 5/23/2024 Scheduled Guests Sahiba Kaur Preston Komara Host and Producer - AJ Hoffman Equipment Tech and Producer - Abby Young Video Podcast https://youtu.be/eWkTFv0DB7Q

This episode of the Flow Radio podcast features Dr. Jef J. J. Van den Hout, associate researcher at the Eindhoven University of Technology and the Erasmus University Rotterdam, the founder of Flow Concepts, and one of the world's foremost experts on flow in teams. Dr. van den Hout joins Flow Research Collective Chief of Staff Ryan Wickes and Chief Science officer Dr. Michael Mannino to talk about how leaders and teams can spark flow and optimize collaboration in the workplace. In This Episode: 0:00 Introduction 01:28 Team Flow vs. Individual Flow 04:19 The Importance of Mutual Accountability 10:12 The Role of Context in Team Flow 15:36 The Default Mode Network in Team Flow 19:39 Facilitating Team Flow Conversations 22:27 Barriers to Team Flow 27:58 The Impact of Team Flow on Individual Happiness 35:05 Constructive Criticism and Team Flow 42:07 The Flow Cycle in Individual and Team Flow 43:52 The Future of Team Flow Research About The Guest: Dr. Jef van den Hout, PDEng, has earned his Ph.D. with a focus on understanding and measuring team flow. He applies this knowledge to enhance team performance in professional settings. As the creator of Flow Concepts, Jef leads efforts to simplify complex team interactions and foster exceptional outcomes. He's an associate researcher with the Eindhoven University of Technology and the Erasmus University Rotterdam. His research spans several key areas: flow, team flow, optimal collaboration, sustainable performance, and challenge-based learning environments such as innovation ecosystems and professional learning communities. Jef is driven by a clear mission: to connect scientific research with real-world practice. He shares, “I find it fascinating to unravel climates for optimal collaboration and moments of team flow. Especially, if the ambitions could lead to something just beautiful, something unusually good, or something completely innovative! ” Episode Resources: Website: https://flowconcepts.nl/ LinkedIn: https://www.linkedin.com/in/jefvandenhout/ X: https://twitter.com/jefvandenhout Facebook: https://www.facebook.com/jef.vandenhout Flow Radio Is Presented By Flow Research Collective Are you an entrepreneur, a leader, or a knowledge worker, who wants to harness the power of flow so you can get more done in less time with greater ease and accomplish your boldest professional goals faster? If the answer is yes, then our peak-performance training Zero To Dangerous may be a good fit for you. Flow Research Collective is a leading neuroscience research and training company. If you're interested in learning the science-backed techniques we used to train top executives at Facebook, Audi and even the Navy SEALs, click the link here: ⁠https://www.flowresearchcollective.com/zero-to-dangerous/overview⁠ Follow Flow Research Collective: YouTube: ⁠https://www.youtube.com/@flowresearchcollective⁠ Instagram: ⁠https://www.instagram.com/flowresearchcollective⁠ LinkedIn: ⁠https://www.linkedin.com/company/flowresearchcollective⁠ X: ⁠https://twitter.com/thefrc_official⁠ Facebook: ⁠https://www.facebook.com/flowresearchcollective⁠ Spotify: ⁠https://open.spotify.com/show/6RQY0d5rdlEiinHEtfWy6A⁠ Website: ⁠https://www.flowresearchcollective.com⁠ Flow Research Collective was founded by Steven Kotler, one of the world's leading experts on human peak performance. He is an award-winning journalist and author with over ten bestselling books.

On this week's episode, we feature our Chief Science Officers from Midland High. Brooklyn Jones and Sophia Knarr discuss their positions as CSOs for their school and how this can help them after high school. Jones aims to be a computer scientist, while Knarr discusses her future as an environmental scientist, as well as the recent sustainability fair they brought to life through the process of one of their action items as acting CSOs. View the video version of this podcast here on Youtube https://youtu.be/2JZ3EbSEdh0 Guests: Sophia Knarr Brooklyn Jones MPS Connections Producer and Host: AJ Hoffman Equipment Support: Abby Young

Holden Thorp became Editor-in-Chief of the Science family of journals on 28 October 2019. He came to Science from Washington University, where he was provost from 2013 to 2019 and professor from 2013 to 2023. He is currently a professor at George Washington University and on leave to serve as the Editor-in-Chief at Science.Thorp joined Washington University after spending three decades at the University of North Carolina at Chapel Hill (UNC), where he served as the 10th chancellor from 2008 through 2013.Thorp earned a bachelor of science degree in chemistry from UNC in 1986. He earned a doctorate in chemistry in 1989 at the California Institute of Technology, working with Harry B. Gray on inorganic photochemistry. He completed postdoctoral work at Yale University with Gary W. Brudvig, working on model compounds and reactions for the manganese cluster in the photosynthetic reaction center. He holds an honorary doctor of laws degree from North Carolina Wesleyan College and is a fellow of the American Academy of Arts and Sciences, the National Academy of Inventors, and the American Association for the Advancement of Science. Thorp cofounded Viamet Pharmaceuticals, which developed VIVJOA (oteseconazole), now approved by the FDA and marketed by Mycovia Pharmaceuticals. Thorp is a venture partner at Hatteras Venture Partners, a consultant to Ancora and Urban Impact Advisors, and is on the board of directors of PBS, the College Advising Corps, and Saint Louis University. He serves on the scientific advisory boards of the Yale School of Medicine and the Underwriters' Laboratories Research Institutes.Thorp is the coauthor, with Buck Goldstein, of two books on higher education: Engines of Innovation: The Entrepreneurial University in the Twenty-First Century and Our Higher Calling: Rebuilding the Partnership Between America and its Colleges and Universities, both from UNC Press.Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)

 Best of Business 2023 - Part 4 2023 AZ TRT S04 EP52 (215) 12-31-2023 What We Learned This Week: Alan Payne on the Rise & Fall of Blockbuster Arthur Smith on Reality TV & Sports Trevor Pan of Bidbird on shipping efficiency & container skins Dr. Chuck & Francis of Ally Bio on Cannabis Innovation Chris Owen of J Galt on Commercial Credit Host Matt on Business Assets   Seg. 1 – Clips From: Built to Fail: The Inside Story of Blockbuster's Inevitable Bust w/ Alan Payne AZ TRT S04 EP34 (197) 8-27-2023     What We Learned This Week: ·         Blockbuster started in 1985, and scaled quickly after Wayne Huizenga purchased it in 1987, 10,000 stores at its height, dominant video rental co. ·         Alan Payne instituted the Video Rental model of HEB to the Blockbuster franchises he ran – segmented movies to rent new ones for more ·         Wayne Huizenga was a stellar Founder who built 3 fortune 500 companies – Waste Mgmt, Blockbuster, and Auto Nation ·         Viacom purchased Blockbuster in 1994 for $8.4 billion, and went on to lose 75% of the value over the next decade + ·         Competition was fierce from Hollywood Video, Redbox and then in 1997 by a new DVD rental by mail company called Netflix ·         Netflix scaled into the internet company it always wanted to be with streaming in 2009   Guest: Alan Payne Alan Payne spent thirty-one years in the movie rental business, the last twenty-five of those as a Blockbuster retail franchisee. He took over a small group of Blockbuster stores in 1993 and grew it into one of the largest and most successful chains in the company. He finally closed his last store in 2018, more than eight years after Blockbuster filed for bankruptcy. Book: Built to Fail: The Inside Story of Blockbuster's Inevitable Bust   From the Back Cover Blockbuster was phenomenally successful in its early years and made thousands rich beyond their wildest dreams. But it was consistently outsmarted and outmanaged by smaller companies. And the challenges began earlier than you think--long before Netflix was even an idea in the minds of founders Reed Hastings and Marc Randolph. Blockbuster became one of the most iconic brands in the history of American business, but it cracked at the first sign of a challenge. From its founding, Blockbuster was a company built to fail. Link: HERE     Full Show: HERE   Seg. 2 – Clips From: TV Tales of The Unbreakable Jay Glazer to Creating Competition Shows from American Ninja Warrior to Hell's Kitchen w/ Arthur Smith AZ TRT S04 EP28 (191) 7-16-2023     What We Learned This Week: ·   Jay Glazer's Unbreakable mindset gets him thru ‘the gray' of his daily life, working on his mental health ·   Arthur Smith's describes Reach as striving for our full potential to create amazing things ·   Creation of TV Classics like American Ninja Warrior & Hell's Kitchen   Arthur Smith, the chairman of A. Smith & Co. Productions, is a pioneering veteran of nonfiction television, known for creating and producing some of the longest running unscripted series in history, including Hell's Kitchen and American Ninja Warrior. Smith was honored as one of Variety's “Titans of Unscripted TV” in 2022, inducted into the Realscreen Awards Hall of Fame in 2021, awarded Broadcasting and Cable's “Producer of the Year” in 2020, Nominated for several Emmy Awards, and received dozens of awards, including NAACP Awards, Realscreen Awards, and Critics Choice Awards. Smith embarked on his career in television as a twenty-two-year-old wunderkind, talking his way into sports production at CBC in his native Canada. He quickly distinguished himself as a rising star at the network, where he produced three Olympic Games among countless other high-profile events. At the age of twenty-eight, Smith was named the youngest ever head of CBC Sports. His successful run at the network ended when American broadcasting icon Dick Clark lured him to Hollywood to develop and produce a wide variety of entertainment programming. Then as the head of programming and production at FOX Sports Net, Smith played an instrumental role in the launch and growth of this massive entity, before the biggest reach of his life—the creation of his eponymous production company that has thrived for more than twenty years. He lives in Los Angeles.     Full Show: HERE     Seg. 3 – Clips From: Cannabis Innovation by Ally Biotech w/ Dr. Chuck & Francis - AZ TRT S04 EP36 (199) 9-10-2023                    What We Learned This Week Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products Cannabis is competitive and it's all about the product quality. Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry.       The goal of the company is to adopt the practices of big Pharma and make high grade products. FDA and DEA are actually working together. The DEA treats cannabis like any other Schedule One dangerous drug, like cocaine or heroin. Yet it does not have the same affects, nor addictive qualities. Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Cannabis is a good alternative for pain mgmt.     Guests:   Dr. Chuck Johnson, CSO at Ally Biotech  After earning his BA in Chemistry from Northwestern University and PhD in Analytical Chemistry from Virginia Tech, Dr Chuck refined his craft while working The Procter & Gamble Company, Koch Industries, and Danaher, and expanded his scope of knowledge while working and consulting for DuPont, BATF, FBI, Army Corps of Engineers, Chiyoda Engineering, Toyo Engineering, Japan Gas Company, Yamato, Fisher Scientific, VWR Scientific Products, among others. Chuck brings with him experience with FDA regulatory compliance, LEAN (TPS) principles in Product Development and Manufacturing, competitive market analysis, mergers and acquisitions and technical sales. More recently he has provided consultation services and served as the Chief Science and Operations Officer in the Hemp and Cannabis sectors, including industrial farming, extraction, refining, GMP production, nutraceuticals, and FDA compliance.    Francis Baczek, V.P. of Business Development at Ally Biotech  Francis Baczek serves as Vice President of Business Development at Ally Biotech, a provider of leading-edge bioactive delivery solutions for cannabinoids. Baczek brings significant product development experience in the medical cannabis sector. Since 2013, he has been formulating precision-dosed edibles as lead cannabis chef for Uncle Herb's Health Center, a licensed Arizona operator. Baczek is credite      https://allybiotech.com/about-team/     Full Show: HERE     Efficiency in the Supply Chain by a New Container Invention w/ Trevor Pan of BidBird AZ TRT S04 EP41 (204) 10-15-2023   Things We Learned This Week Malcolm McLean was the inventor of the shipping Container, and a key person in trade & globalization BidBird invented a container skin, a smooth panel for the side to reduce wind resistance & improve fuel efficiency Patent process and Patent Cooperation Treaty to register an invention in foreign countries Building a Prototype and doing a road test with a Truck plus a Container on a race track   Guest: Tevor Pan, BidBird Principal Architect - February 2018 - Present Undergraduate Professional Degree - Landscape Architecture, Colorado State University,  Fort Collins, Colorado 2003 Master Degree - Frank Lloyd Wright School of Architecture, Scottsdale, Arizona 2006   o  Twitter o  LinkedIn     https://bidbird.co/about THE FIRST CONSTRUCTION MARKETPLACE, AT YOUR FINGERTIPS.   Trevor Pan, BidBird Founder & registered Arizona architect.   Spending 21 years as an architect immersed in construction, manufacturing, and design, I've built a unique understanding of the construction industry's constant movements and challenges. I know that construction professionals are exhausted by the RFP game—and the collusion that can come along with it.   I've seen invasive service platforms that trap users into thinking they're a lead generating machine, but then unethically charge them thousands with no quality results.   When I set off to launch BidBird, I wanted to eliminate the red tape and corruption for suppliers, manufacturers, contractors, and building owners. And when my barber approved the irresistible alliteration of the name, BidBird was born.   BidBird is the new way for construction professionals to achieve a constant-but-necessary thing: capture competitive bids for their materials through an efficient process.   At its core, our mission is simple. We connect construction industry professionals around the country through an honest platform that doesn't cost users unreasonable fees, or their dignity.   With its simplicity comes big things. BidBird is an opportunity to beat out the “big guys” by just a penny, equalizing the hunt for businesses around the country.   We strive to combine high-value jobs + the innovation to evolve with construction professionals' needs to transform businesses, one bid at a time.         Full Show: HERE   Seg. 4 – Clips From: Building Commercial Credit w/ Chris Owen of J. Galt AZ TRT S04 EP45 (208) 11-12-2023   Things We Learned This Week J. Galt Helps Small Businesses Optimize Cashflow & Manage Growth Helping Business Owners Access Loans & Credit, Endangering Their Personal Credit & Family Assets Small Business is the backbone of a community, when it thrives, so does the community 3 Types of Credit - Personal, Business & Commercial Credit - Business need to build their Commercial Credit     Guest: Chris Owen  LKIN: HERE Helping Business Owners Access Loans & Credit   Endangering Their Personal Credit & Family Assets When small businesses prosper, then the community also thrives. The passion I have for helping fellow entrepreneurs succeed is something I've fostered my entire life. As an advocate and advisor for small businesses I have seen the challenges they face firsthand. When businesses fail, they leave an average of $80K for the business owner and their family. Knowing these daunting stats, it has become my life's mission to help protect these incredible small businesses that are the bedrock of our economy. Can you imagine what your small business would look like in 12 months if… ✅     You didn't get turned down for the loan, credit card, or line of credit you needed? ✅     Your access to loans and credit didn't impact your personal credit or put your family home at risk? ✅     You had the money you needed to expand and meet new opportunities?   J. Galt: https://www.jgalt.io/cowen     Full Show: HERE     Rethinking What is an Asset AZ TRT S04 EP39 (202) 10-1-2023     What We Learned This Week:   ·         Knowledge as an Asset  ·         Industry You Work in as an Asset   ·         Your Network as an Asset  ·         Leverage as an Asset   ·         Focus as an Asset  ·         Traditional Investment Assets – Appreciating vs Harvesting       Full Show: HERE     Investing Topic: https://brt-show.libsyn.com/category/investing   Tech Topic: HERE   ‘Best Of' Topic: https://brt-show.libsyn.com/category/Best+of+BRT      Thanks for Listening. Please Subscribe to the BRT Podcast.     AZ Tech Roundtable 2.0 with Matt Battaglia The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business.  AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving.  Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more…    AZ TRT Podcast Home Page: http://aztrtshow.com/ ‘Best Of' AZ TRT Podcast: Click Here Podcast on Google: Click Here Podcast on Spotify: Click Here                    More Info: https://www.economicknight.com/azpodcast/ KFNX Info: https://1100kfnx.com/weekend-featured-shows/     Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.  

In September 2023, Dr. Arati Prabhakar, Chief Science and Technology Advisor to the President of the United States, joined Download on Tech host and ITI's President and CEO Jason Oxman for an insightful dialogue on safe and responsible AI. As a key voice on AI in the Biden Administration, Dr. Prabhakar shares with Jason strategic initiatives and partnerships shaping the responsible integration of AI into the U.S. tech landscape and highlights the collaborative efforts between the tech industry and the public sector to forge trustworthy AI systems.

Cannabis Innovation by Ally Biotech w/ Dr. Chuck & Francis - BRT S04 EP36 (199) 9-10-2023                    What We Learned This Week Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products Cannabis is competitive and it's all about the product quality. Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry.       The goal of the company is to adopt the practices of big Pharma and make high grade products.       FDA and DEA are actually working together. The DEA treats cannabis like any other Schedule One dangerous drug, like cocaine or heroin. Yet it does not have the same affects, nor addictive qualities.       Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Cannabis is a good alternative for pain mgmt.       Guests:   Dr. Chuck Johnson, CSO at Ally Biotech  After earning his BA in Chemistry from Northwestern University and PhD in Analytical Chemistry from Virginia Tech, Dr Chuck refined his craft while working The Procter & Gamble Company, Koch Industries, and Danaher, and expanded his scope of knowledge while working and consulting for DuPont, BATF, FBI, Army Corps of Engineers, Chiyoda Engineering, Toyo Engineering, Japan Gas Company, Yamato, Fisher Scientific, VWR Scientific Products, among others. Chuck brings with him experience with FDA regulatory compliance, LEAN (TPS) principles in Product Development and Manufacturing, competitive market analysis, mergers and acquisitions and technical sales. More recently he has provided consultation services and served as the Chief Science and Operations Officer in the Hemp and Cannabis sectors, including industrial farming, extraction, refining, GMP production, nutraceuticals, and FDA compliance.    Francis Baczek, V.P. of Business Development at Ally Biotech  Francis Baczek serves as Vice President of Business Development at Ally Biotech, a provider of leading-edge bioactive delivery solutions for cannabinoids. Baczek brings significant product development experience in the medical cannabis sector. Since 2013, he has been formulating precision-dosed edibles as lead cannabis chef for Uncle Herb's Health Center, a licensed Arizona operator. Baczek is credite      https://allybiotech.com/about-team/   About Ally Biotech:  Headquartered in Payson, Arizona, Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products since 2019. The company recently acquired the Chill Pill line of products. The company's Lipofusion® delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. Ally Biotech offers product development services, and manufacturing-ready, water soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company's products undergo rigorous testing for purity, potency, safety and efficacy at third-party laboratories. For more information, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com.    About Chill Pill:  The Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry. Formulated using hemp seed oil, Chill Pills are easy to absorb, metabolize, and come in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed. Chill Pill is owned and operated by Ally Biotech, a company committed to harnessing the power of science to create innovative THC products, such as their patented Lipofusion® technology. For more information, visit ChillPillsAZ.com.     Notes:   Seg 1   Cannabis is competitive and it's all about the product quality. Growing cannabis is a seasonal business.   Ally biotech has been around for two years, circa 2021. Working on a new product called Lipo fusion to be determined one will come out.   Ally purchase a product called chill pill in 2023 and they've tightened up the product with some of their own technology to stabilize the brand. They have three or four products.   Dr. Chuck has a manufacturing and farmer background. SOP of the product is the franchise potential.   Chill pill can be taken and a gummy or sugar edible. THC is 10 g per pill with other variations of 510 and even up to 125 g. Can also take it in liquid form.   They got a nighttime version CBN to stay asleep. Another version CBG daytime to give you energy. Any time product with non-enhanced oil.   There's an ongoing discussion of medicinal use for cannabis, vs recreational. Dr. Chuck believes all cannabis products is medicine.   The goal of the company is to adopt the practices of big Pharma and make high grade products.   Seg 2 They are creating pills, but not smokables. AZDHS or department of health has to monitor every product sold in Arizona.   They have the studies so you can check all the tests and confirm their product is safe.   In reality you can't find tests on prescription drugs, and many drugs are imported from Asia. It's hard to know what the actual quality is.   The chill pill products are made in Arizona using plants that must also be grown in Arizona. There is a strict chain of custody on plant growing as well as all types of test things like examples testing for metals.   The ingredients of THC and CBD actually come from the same plant. When they make their product they buy the extract from other easy growers and use easy labs for testing.   Overall the company has a model that would be easy to copy from the state of Arizona to other states.   Quality of most cannabis products is stagnant per Dr. Chuck. Any cannabis product they're making cannot claim use.   FDA costs are huge to run tests and prove use cases. Very few cannabis companies have the budget to do it. Estimated cost of $15 million to pass the FTA test. Cannabis products are not bad for you.   What most people don't realize is that over-the-counter drugs like Tylenol if you take 2 1/2x the recommended dose recommended dose it can actually be toxic.   Cannabis products you take microdoses, it would take 100 times the recommended doss to be toxic.     Seg 3   FDA and DEA are actually working together. The DEA treats cannabis like any other schedule one dangerous drug, like cocaine or heroin. Yet it does not have the same affects nor addictive qualities.   On schedule 2 are many pain medicines like oxycodone. These medicines are extremely dangerous and can be addictive.   Alcohol though regulated it's not on any drug schedule, it's totally legal and only has age restrictions.   Hundred milligrams per charge 10 per unit. Quick factor female cannabis state to state it's federally illegal when you've committed a crime. No interstate commerce. Cannabis must all be within the state.   It's highly regulated and only legal in about 60% of the states. It is unknown how the DEA will handle cannabis long-term. Arizona has a very viable medical market for cannabis as well as for pain medication.   Cannabis can be used for pain and it is less habit-forming. Medicines like steroids which help a lot of things in the body, also have many negative side effects. Any drug you taking must be careful of the dosage and it needs to be controlled.   Many pain medication's have very serious side effects as well as the potential for problems with overdosing. Per Dr. Chuck you take one chill pill at 5 mg and it will bring down swelling and pain in your body may be failing.     Seg 4   Take too much aspirin you can actually overdose very quickly. This is because aspirin is hard on the liver and can cause metabolism issues. 500 mg plus she took an OxyContin also at 500 mg could wind up having an overdose.   Steroids can do damage to the body but it actually takes a lot of time.   CBD and THC hit different receptions in your body receptors in your body and work well together. CBG actually helps with sleep.   Francis has a very personal story or cannabis treatment helped him with focus. Per Francis also helped relieve tumor size and his cancer treatment a few years ago.   He credits cannabis for a faster recovery. Initially during cancer treatment he was taking Percocet pain pills, also taking nausea drugs which he did not want to. Took Cannabis and it took care of everything.   Francis believes that doctor said prescribe cannabis to get people off opiates.   More information go to life is chill or chill pill a Z. They sell wholesale to dispensaries. No sugar in the product.   Try it for what helps you. The chill drops are the first Lipo products you can put the drops in the water. Go to jars locations to get their product.   Both Dr. Chuck and Francis believe and hope THC will be taken off the schedule one drug listing.       Cannabis Topic: https://brt-show.libsyn.com/category/Cannabis-Hemp-Marijuana   Tech Topic: https://brt-show.libsyn.com/category/Tech   Best of Biotech from AZ Bio & Life Sciences to Jellatech: HERE   Thanks for Listening Please Subscribe to the Podcast   AZ Tech Roundtable 2.0 with Matt Battaglia The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business.  AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving.  Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more…    AZ TRT Podcast Home Page: http://aztrtshow.com/ ‘Best Of' AZ TRT Podcast: Click Here Podcast on Google: Click Here Podcast on Spotify: Click Here                    More Info: https://www.economicknight.com/azpodcast/ KFNX Info: https://1100kfnx.com/weekend-featured-shows/   Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.  

Get ready for an extremely informative episode on the importance of teamwork between hygienists and dentists. What makes this episode truly unique is our honored guest, Dr. Nolan, marking the very first appearance of a dentist on our show! Dr. Nolan brings to light the fundamental role of hygienists as the cornerstone of dental practices, emphasizing the connection between successful practice management and the seamless partnership of dentists and hygienists. You won't want to miss this one! Dr. Nolan attended the University of Illinois where he studied chemistry followed by Midwestern University for his DMD in 2014. His research focus is on the development of novel nanomaterials for use in preventative dentistry. He has published on a wide scope of topics including toxicology, remineralization dynamics, and nanotechnology. He is currently the Chief Science officer for Elementa Oral care, and has worked extensively on the development of plant based nanoparticles for their unique anti caries applications.

In this episode, Dr. Will Cole is joined by AG1's Chief Science and Nutrition Officer, Dr. Ralph Esposito. By showing us the importance of various nutrients for enhanced longevity and optimal health, Dr. Esposito shows us what both conventional MDs and the health world get wrong about nutrition and optimal health. From the most common nutrient deficiencies to be aware of, what we get wrong about recommended daily intakes, what supplement + food labels actually mean, and why nutrient synergy is key to overcoming deficiencies, this episode answers every question you've ever wanted to know about nutrients. Plus, he shows us the benefits of AG1 and why it's so much more than an influencer green drink. For all links mentioned in this episode: www.drwillcole.com/podcastPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Thank you to AG1 for sponsoring this episode. You can visit DrinkAG1.com/willcole for a free 1 year supply of vitamin D and 5 free travel packs Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

New Zealand cannot arrest its way out of the gang problem. That's according to a report by the Chief Science Advisory - requested to inform policy for reducing gang harm. It instead calls for improvements in addressing related factors such as family harm, youth offending and drug use. Co-author Tracey McIntosh says legal action over simply being associated with gangs causes collateral damage. "That's largely with children and with women. And it means you have much more distrust in a community and those young people who you actually don't want to enter into a pathway of gangs actually feel that they have no other opportunity." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Moderator: Tom Reuner, Executive Research Leader, HFS Panelists: Angela Johnson, Partner - Head of Capital Formation, Fifth Wall Armen R. Kherlopian, Ph.D., Chief Science and Innovation Officer, Covenant Venture Capital Rajesh Rajappan, Senior Vice President - Global Markets, Hitachi Vantara Nitin Rakesh, CEO & MD, Mphasis Ted Shelton, Expert Partner, Bain & Company Session Description: HFS has outlined the vision, but how do we operationalize the autonomous enterprise? Many organizations still struggle to scale their low-level automation projects. Is it realistic to expect machines will make decisions without human interaction? How should we adapt the innovation agenda to finally get data and workflows out of silos? We'll hear from leaders driving the innovation agenda discuss and debate these questions: How do you design the innovation agenda to enable the autonomous enterprise? How do we need to think about the operating model? What will the most important change agents be: next-gen AI and industry cloud or culture and governance? How do you safeguard the necessary skills amid the war for talent?

We found our previous episode with Frank G. Howard, the CEO of GeneIQ, so interesting and important that we wanted to dive even deeper into pharmacogenomics with Dr Tariq Adwan, the Chief Science officer of GeneIQ. The short definition of pharmacogenomics is the science of determining the genetic variability that influences physiological response. This means that instead of a whole lot of trial and error with medications, people can get the medication that is genetically most likely to be accepted by the body. This means less side effects, and less medications to treat those side effects, along with many other benefits. Learn more about this new science, the benefits and what it takes to get this program started for someone truly in need. Knowing what medications are right for each person can mitigate the need to throw many medications, on average 15 medications for seniors, to treat their health concerns.

Whether as a patient, a caregiver, a neighbour or a friend, chances are, one day, we will all be touched by Alzheimer's or dementia. This disease steals our memories and cruelly robs us of our loved ones, often when we need them the most. But, there is hope and momentum in the world of Alzheimer's research. In fact, a new theory suggests that Alzheimer's could even be an autoimmune disease. In this episode of Your Complex Brain, we speak with Dr. Donald Weaver and Dr. Saskia Sivananthan. We'll also hear from Lindsay Bongard-Batori, who lost her mother Barbara to Alzheimer's. Featuring: Dr. Donald Weaver – Neurologist, medicinal chemist & Senior Scientist with the Krembil Brain Institute at UHN. Dr. Weaver is an internationally recognized research leader in university-based drug design and discovery for neurological disorders. Dr. Saskia Sivananthan – Neuroscientist & Chief Science and Knowledge Translation Officer at the Alzheimer Society of Canada, overseeing the Alzheimer Society Research Program, a dementia research priority setting leader. Lindsay Bongard-Batori - Lost her beloved mother Barbara to Alzheimer's in 2020, and hopes her story will help others caring for their loved ones.Additional resources: Dr. Donald Weaver's lab websiteUHN – Dementia & Neurodegenerative DisordersAlzheimer Society of Canada (for information on latest research awards, patient stories, help for caregivers, provincial chapters)Alzheimer Society of Canada HotlineLandmark Study: Navigating the Path Forward for Dementia in Canada(VIDEO) A New Theory of Alzheimer's (featuring Dr. Weaver)(VIDEO) Living with Dementia: A Caregiver's Perspective(VIDEO) Risk Factors for Alzheimer's and Dementia(PODCAST) What is it Going to Take to Cure Alzheimer's (featuring Dr. Weaver + Patty Kim)The Krembil Brain Institute, part of University Health Network, in Toronto, is home to one of the world's largest and most comprehensive teams of physicians and scientists uniquely working hand-in-hand to prevent and confront problems of the brain and spine, such as Parkinson's, Alzheimer's, epilepsy, stroke, spinal cord injury, chronic pain, brain cancer or concussion, in their lifetime. Through state-of-the-art patient care and advanced research, we are working relentlessly toward finding new treatments and cures.Do you want to know more about the Krembil Brain Institute at UHN? Visit us at: uhn.ca/krembilTo get in touch, email us at krembil@uhnresearch.ca or message us on social media:Instagram - @krembilresearchTwitter - @KBI_UHNFacebook - https://www.facebook.com/KrembilBrainInstituteThanks for listening!

Scott Jones talks about a wide range of topics In his visit, from his role as Chief Science Officer to his latest interests in music to his family's version of his new job title.

Scott Jones, Chief Scientific Officer at BioBridge Global, talks about his job in a snippet of his upcoming appearance on Hearts Afire.

In this special podcast we will focus on the changes in recommendations for CV Risk Reduction published in the 2023 American Diabetes Association's Standards of Care. The report is available at:   https://professional.diabetes.org/content-page/practice-guidelines-resources    Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Robert A. Gabbay, MD, PhD, Chief Science and Medical Officer, American Diabetes Association

Barcelona has emerged as one of the EU's top startup hubs, and we wanted to learn about the factors that set the city up for success in this space, as well as how European and American cities can contribute to innovations in the science and technology spheres. We sat down with Alexis Roig, the CEO and Barcelona's Chief Science and Technology Envoy, to learn more about his role in connecting cities, foreign affairs, and science diplomacy. The Europe Desk is a podcast from the BMW Center for German and European Studies at Georgetown University in Washington, DC. It brings together leading experts working on the most pertinent issues facing Europe and transatlantic relations today. Music by Sam Kyzivat and Breakmaster Cylinder Design by Sarah Diebboll. Leadership: Flora Adamian, Jakob Winkler. Production by Flora Adamian and Drew Fenner. Communications by Shelby Emami, Ryan Conner, Mason Kane, Sophie al-Mutawaly, and Flora Adamian. https://cges.georgetown.edu/podcast   Twitter and Instagram: @theeuropedesk If you need more information about the Center's events, or have any questions or feedback, please email: theeuropedesk@georgetown.edu.

December 12, 2022: A special episode today. Interviews with cutting edge innovation leaders direct from the floor of HLTH ‘22:Taha Kass Hout, Vice President Machine Learning and CMIO for AWsNeil Sharma, Executive Vice President at Sword HealthErich Huang, Chief Science & Innovation Officer and Tarun Galagali, Product Marketing & Product Strategy for OnduoCharlie Lougheed, CEo and Co-Founder of AxuallSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week Health

Are you already tapping into digital technologies to transform the way you compete, collaborate, and connect? At the launch of Siemens Xcelerator, an open digital business platform, Siemens Digital Industries CEO Cedrik Neike welcomed three guests whose companies have made big strides in their digital transformations: Laura Matz, Chief Science and Technology Officer at Merck, spoke about how digitalization is speeding up the development of therapies. Patrick Verwer, CEO of Govia Thameslink Railway, or GTR, presented how digitalization is helping to deal with growing passenger volumes on legacy infrastructure. And Trond Skjellerud, CEO of Elvia, talked about managing the grid in the age of electric mobility. Host Alex Chavez guides you through this episode. Siemens Xcelerator: www.siemens.com/xcelerator

Dr. Jeremy Babendure, Executive Director at the SciTech Institute, talks about his first vision of creating opportunities for students to get involved in STEM through his CSO's initiative. A vision that has made its way all the way to The White House because of students' work and dedication to STEM. Learn all about this initiative in today's episode.

In this episode of Curbside Consults, we examine the latest standards of medical care published by the American Diabetes Association (ADA). We are joined by Bob Gabbay, who is Chief Science and Medical Officer at the American Diabetes Association, an Associate Professor of Medicine at Harvard Medical School, and one of the authors of the ADA's new 2022 Standards of Medical Care in Diabetes document.

In this episode, Jess interviews our CSO Natalie and Founder Lynndsey about Natalie's Role as our Chief Science officer, and the ladies get into a discussion all about evidence-based training design.    They cover periodization, progression, rest periods, deloads, exercise selection, and how to adjust these things for a beginner or someone with a chronic disease or condition.     

In this episode, Françoise von Trapp interviews Laura Matz, CEO of Athinia™ and Chief Science and Technology Officer of Merck KGaA, Darmstadt, Germany, about the growing need for data collaboration between materials suppliers and semiconductor device manufacturers, and the solution she helped create. Over the past 10 years, more new materials have been introduced into semiconductor manufacturing at each device node. At the same time, processes continue to tighten. This is increasing sensitivities to materials variations. Because of this, materials companies have to publicly communicate on excursions in the materials supply chain. Until now.  Matz explains how a secure data ecosystem platform can use Big Data and AI to solve these issues. She provides details on how this platform addresses both IP security and cybersecurity. The platform she describes, Athinia™, was launched in December 2021. This secure data collaboration platform allows semiconductor device manufacturers and materials suppliers to share, aggregate, and analyze data to unlock efficiencies and time to market while improving quality, supply chain, and sustainability.   Six months in, Matz has some exciting news to share about a collaboration with Micron. She also talks about her role in conceptualizing this platform and bringing it to life.  Athinia - Data for Pioneers Building a secure data ecosystem to solve some of the toughest semiconductor industry problems.

Excited to have Chief Science officer, Kevin Longoria, from Biostrap, a biometric wearable that measures/monitors everything from arterial health, heart rate, sleep, heart rate variability (HRV), movement, and much more. Biostrap is on a mission to provide the world's most advanced, science-based platform to improve global health.To get 10% off any wearable, head over to www.biostrap.com and enter the code JOELEVAN at checkout.There's lots of fitness trackers out there such as FitBit, Whoop, etc, but Biostrap is my favorite based on the quality control of the data and the way they gather it. In this episode we dive into how Biostrap is able to predict possible sickness or injury, improve sleep, the fascinating things they're doing with heart health, and the studies they've conducted on fitness products and supplements.If you're looking for holistic health coaching and getting to the root cause of your issue, or you want to lose weight permanently through a holistic method that focuses on mindset, nutrition, detox, and habit mastery, then  DM me “I'M READY”@joelevancoaching or email me info@joelevancoaching.com [www.joelevancoaching.com]Timeline3:00 - What makes Biostrap unique and different from other wearables5:47 - Are we still a long way from collecting valuable data?8:00 - How Biostrap determines how you might be at risk of injury or other sicknesses12:35 - What Biostrap is used for mostly by users16:37 - How Biostrap helps with heart health19:50 - How Biostrap predicted the C-virus in individuals based on arterial elasticity21:17 - How athletes are using the Biostrap device22:45 - Biostrap Labs: how you can test the efficacy of your product with Biostrap26:57 - Efficacy of soft shell HBOT chambers 27:11 - How saunas improved sleep drastically29:58 - How the Neufi helped with HRV and less pain36:50 - What is Biostrap SleepLab and how they can tell you your circadian rhythm Other Resources/LinksBiostrap's website - use code JOELEVAN for 10% off at checkout

Demand for a local seaweed-based biostimulants jumped 200 percent this autumn compared to the same time last year, partly driven by price hikes for synthetic fertilisers, as the war in Ukraine affects global supplies. AgriSea has been making biostimulant products for 25 years, and says demand is also growing as farmers become more conscious of where farm inputs come from. AgriSea collects seaweed from remote shores of coastal New Zealand and brews the harvest into a nutrient-rich concentrate at a factory in Paeroa. The company is also developing a seaweed farm in the Hauraki Gulf. The final product is a bio-stimulant, which enables farms and orchards to improve outcomes for soil, pasture, plant and animal health. Seaweed is a burgeoning sector in New Zealand, and globally, the seaweed sector is estimated to be worth more than $20 billion. Kathryn speaks to the chief executive of AgriSea, Clare Bradley about the industry. She also speaks with Fonterra's Chief Science and Technology Officer, Jeremy Hill, initiatives Fonterra is exploring to reduce greenhouse gases, including trialling a supplement for cattle containing Asparagopsis seaweed.

Sea levels are rising twice as fast as thought in New Zealand, significantly reducing the amount of time authorities have to respond. But there's a new weapon in regional and unitary councils' armoury to combat the pressures on communities of climate change, as well as for managing land, air, and water resources. The sector's inaugural Chief Science Advisor is Dr Chris Daughney. Te Uru Kahika created this role in recognition of increased pressure on local and regional government from sea level rise, among other pressing environmental issues. Kathryn speaks with Dr Daughney, who is also Chief Science advisor at NIWA.

SHOW NOTES (Bonus Pre-Season Episode) Evidence indicates the Stegosaurus did not swish its spiked tail back and forth like a Medieval weapon, but rather used it for locomotion and communication, and when need be for defense. Morrison Natural History Museum Director Matthew Mossbrucker provides the non-gory details in his interview with Michelle Howell. Dinosaur Ridge volunteer Jim Watson surmises how the Stego may have sounded — his interpretation is unlike any Hollywood version you've heard. Finally Dr. Nicole Peavy of the Colorado Department of Transportation (CDOT) talks about the work of Mitigation Paleontology, and what happens with fossils found on road construction sites. The Stegosaurus used its tail like a third leg! It helped move the animal, and also could be used to communicate with other Stegosaurus, and defend the animal from predators. Matthew Mossbrucker discusses the anatomy of the tail, including the lump of bone called the fourth trochanter, that served as a muscle attachment knob for the caudofemoralis, a muscle found in nearly all animals with tails. In 2009, Mossbrucker and Dr. Robert Bakker studied the tail and published “The Symposium on Stegosauria” In our conversation, Mossbrucker mentions Quarry 13 in Como Bluff, Wyoming which is referenced in this thorough wikipedia post if you would like more context. Dr. Nicole Peavey mentioned paleobotany finds at Denver International Airport, more can be seen on the Denver Museum of Nature and Science website here. Peavy also referenced the Castle Rock Rainforest uncovered during a highway project. At the time the Dr. Kirk Johnson (Smithsonian's National Museum of Natural History Director) was with the Denver Museum of Nature and Science, which now holds 10,000 specimens from this site. He wrote an article about the finds that was published in 2003. Peavy also referenced Ian Miller, now National Geographic Society's Chief Science and Innovation Officer, who also worked at the Denver Museum of Nature & Science. Miller has led science research projects on major field expeditions across the western U.S. and Madagascar. If you've never heard how the term “Thagomizer” came about, you must first treat yourself to a popular newspaper comic strip from the 1980s called “The Far Side.” Author Gary Larson in a 1982 comic drew a group of cavemen attending a lecture in which the speaker points to the tail tip of a Stegosaurus. The caption explains the spikes are called Thagomizers "after the late Thag Simmons.” Denver Museum of Nature and Science paleontologist Kenneth Carpenter jokingly used the term at the Society of Vertebrate Paleontology Annual Meeting more than a decade later, and it caught on. Fossil Butte National Monument in Wyoming is the scene of world-renowned fossil finds including 27 types of fish. And as you will learn, in some cases the data is more important than the fossils themselves.   Our theme music was composed by Hansdale Hsu. Additional music titled “Call to Adventure” provided by Kevin MacLeod of icompetech.com via http://creativecommons.org/licenses/by/4.0/ Thank you for listening!  Stay tuned for Season One coming this spring 2022!  

Robert Popovian, PharmD, discusses what the profession of pharmacy can learn from the recent pandemic.

If you're looking for real conversations with real technology leaders about practical solutions, you've come to the right place. In this introductory episode, the 3 hosts from ChaosSearch join us: - Thomas Hazel, Founder, and Chief Science and Technology Officer - Dave Armlin, VP Customer Success and Field CTO - Courtney Pallotta,VP Marketing They're here to kick off the informal, unfiltered, fun conversations to be had on the show. Join us as we discuss: The biggest challenges in the industry today Who the podcast is for The types of conversations featured on the show   To make sure you never miss an episode of Data Legends: Stories from the IT Trenches podcast, subscribe on Apple Podcasts, Spotify, and the website. Listening on a desktop & can't see the links? Just search for Data Legends: Stories from the IT Trenches in your favorite podcast player.